- Business
- Evonik Industries AG (EVK.SW) operates as a leading global specialty chemicals company headquartered in Essen, Germany, with origins tracing back to the 2007 restructuring of RAG AG. The company produces a broad portfolio of specialty chemicals across segments including Specialty Additives for coatings and inks; Nutrition & Care encompassing animal nutrition, health care lipids for mRNA therapies, drug delivery systems, cell culture ingredients, and care solutions such as cosmetic actives and emulsifiers; Smart Materials covering inorganic materials and performance polymers; Performance Materials; and Technology & Infrastructure; with production plants in 27 countries and operations in over 100 countries serving industries like automotive, personal care, pharmaceuticals, and agriculture. Employing around 32,000 people, Evonik generated €15.2 billion in sales and €2.1 billion in adjusted EBITDA in 2024. Recent developments include pausing mergers and acquisitions until 2027 amid a major restructuring involving 2,000 job cuts by end-2026, a focus on biobased solutions and energy transitions, the 2023 acquisition of Novachem for sustainable cosmetics actives integrated into Care Solutions, a partnership with Schneider Electric to automate thermoplastic processing at its Essen site, and showcasing circular polymer innovations at K 2025.